← Back to Search

Expressive Writing for PTSD and Alcohol Abuse (QueST2023 Trial)

N/A

Recruiting

Led By Jillian R Scheer, PhD

Research Sponsored by Syracuse University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (pre-intervention), immediate post-intervention (1 week post first treatment session), and three-month follow-up (3 months post first treatment session)

Awards & highlights

QueST2023 Trial Summary

This trial will test if online writing interventions can help reduce PTSD symptoms and hazardous drinking in sexual minority women, transgender individuals, and/or nonbinary people.

Who is the study for?

This trial is for sexual minority women, transgender individuals, and nonbinary people living in the US who are at least 18 years old. Participants must have internet access, speak English fluently, and have experienced a traumatic event. They should not have had inpatient psychiatric care recently.Check my eligibility

What is being tested?

The study tests online writing interventions aimed at reducing PTSD symptoms and hazardous drinking among queer survivors of trauma. It compares Trauma Expressive Writing and Stigma Expressive Writing against a control group.See study design

What are the potential side effects?

Since this trial involves expressive writing exercises rather than medical treatments or drugs, traditional physical side effects are not expected; however emotional discomfort due to recalling traumatic events may occur.

QueST2023 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (pre-intervention), immediate post-intervention (1 week post first treatment session), and three-month follow-up (3 months post first treatment session)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (pre-intervention), immediate post-intervention (1 week post first treatment session), and three-month follow-up (3 months post first treatment session)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-intervention), immediate post-intervention (1 week post first treatment session), and three-month follow-up (3 months post first treatment session) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in PTSD symptom severity

Change in drinking quantity

Change in hazardous drinking levels

+1 more

Secondary outcome measures

Change in alexithymia

Change in attachment style.

Change in coping.

+16 more

QueST2023 Trial Design

3Treatment groups

Experimental Treatment

Placebo Group

Group I: Trauma Expressive WritingExperimental Treatment1 Intervention

In the trauma condition, we ask participants to write about a traumatic experience, prompting them to write their very deepest thoughts and feelings about the most traumatic experience of their entire life or an extremely important stressful, upsetting, or emotional issue that has affected them.

Group II: Stigma Expressive WritingExperimental Treatment1 Intervention

In the stigma condition, we ask participants to write about an experience of stigma, prompting them to write about their very deepest thoughts and feelings about the most difficult or painful experience of stigma or bias (e.g., prejudice, bullying, rejection, discrimination) based on one or more of their identities (e.g., race/ethnicity, gender identity, sexual identity, religion) that they have faced.

Group III: ControlPlacebo Group1 Intervention

In the control condition, we ask participants to write about their day, prompting them to write about what they did yesterday from the time they got up until the time they went to bed.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalOTHER

2,932 Previous Clinical Trials

13,198,392 Total Patients Enrolled

5 Trials studying Alcohol Abuse

188 Patients Enrolled for Alcohol Abuse

Yale UniversityOTHER

1,851 Previous Clinical Trials

2,738,108 Total Patients Enrolled

6 Trials studying Alcohol Abuse

1,161 Patients Enrolled for Alcohol Abuse

Syracuse UniversityLead Sponsor

48 Previous Clinical Trials

117,469 Total Patients Enrolled

2 Trials studying Alcohol Abuse

1,103 Patients Enrolled for Alcohol Abuse

Media Library

Alcohol Abuse Research Study Groups: Stigma Expressive Writing, Trauma Expressive Writing, Control

Alcohol Abuse Clinical Trial 2023: Stigma Expressive Writing Highlights & Side Effects. Trial Name: NCT05569915 — N/A

Stigma Expressive Writing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05569915 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to join this experiment at present?

"Per clinicaltrials.gov, this specific medical trial is not actively recruiting patients at the present moment as it was last updated on November 6th 2022; however, 348 other studies are currently looking for volunteers to participate."

Answered by AI

What aims does the current experiment seek to accomplish?

"This study's primary objective is to assess Change in PTSD symptoms over Baseline, Immediate Follow-Up (1 week), and Post-Intervention (3 months). Secondary objectives involve measuring patients' Change in impulsivity using the SUPPS-P Impulsive Behavior Scale, their Change in resilience via the BRS Brief Resilience Scale, as well as monitoring their Change in emotion regulation with the DERS Difficulties In Emotion Regulation."

Answered by AI